Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by KPOIndustrieson May 07, 2020 12:42pm
95 Views
Post# 30998489

RE:RE:RE:RE:RE:RE:RE:This dip is just temporary

RE:RE:RE:RE:RE:RE:RE:This dip is just temporary

I appreciate this and this sounds logical. I guess it comes down to risk tolerance.


jjwilson wrote: KPOIndustries;

I'll take a shot at answering your question.  There are many different kinds of investors and investment strategies.  For myself, I do the research and make my decision.  I like to buy before the news to maximize my gain but there is considerable risk in this.  Often I get it wrong but the upside is that when I get it right I get the biggest movement in share price. 

Now, conversely, there are some who like the comfort of actually waiting for the news before they buy.  They don't get the maximum profit but they aren't wrong as often either.  I think there is lots of money waiting on the sidelines to see which company actually gets the contract and starts selling in volume.

Lots of noise and confusion now about what tests are reliable and worthwhile and which aren't.  Lots of doubt about which companies have the contacts and financial resources to get the deals.  I think there are many people willing to trade the excitement and challenge of finding a big score for the "sure thing" that they will get from waiting to see who the actual winner is before investing.

That's the explanation for why there is money waiting on the sidelines.

 

Bullboard Posts